Results of REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl – Intervention Trial) USA
Written by Joyce Smith, BS. Icosapent ethyl, a highly stable and purified formulation of EPA significantly reduced cardiovascular events and triglyceride levels in elderly patients with cardiovascular risk factors who were on statin therapy.





